Business Description
![Ampio Pharmaceuticals Inc Ampio Pharmaceuticals Inc logo](https://static.gurufocus.com/logos/0C000014GF.png?14)
Ampio Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US03209T1097
Description
Ampio Pharmaceuticals Inc is a biopharmaceutical company. It is focused on the development of a potential treatment for osteoarthritis of the knee ("OAK") as part of its OA-201 development program ("OA-201 program" or "OA-201").
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 14.92 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.08 | |||||
Debt-to-EBITDA | -0.03 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 23 | |||||
3-Year EPS without NRI Growth Rate | 26.7 | |||||
3-Year FCF Growth Rate | 25.6 | |||||
3-Year Book Growth Rate | 30.6 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
14-Day RSI | 53.55 | |||||
12-1 Month Momentum % | -12.98 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.41 | |||||
Quick Ratio | 2.41 | |||||
Cash Ratio | 1.72 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 55.8 | |||||
Shareholder Yield % | 288.6 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -123.45 | |||||
ROA % | -92.12 | |||||
ROIC % | -2277.03 | |||||
ROC (Joel Greenblatt) % | -3436.1 | |||||
ROCE % | -132.75 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.02 | |||||
Price-to-Tangible-Book | 0.02 | |||||
EV-to-EBIT | 0.39 | |||||
EV-to-EBITDA | 0.39 | |||||
EV-to-FCF | 0.43 | |||||
Price-to-Net-Current-Asset-Value | 0.02 | |||||
Price-to-Net-Cash | 0.05 | |||||
Earnings Yield (Greenblatt) % | 256.41 | |||||
FCF Yield % | -7512.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ampio Pharmaceuticals Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -10.226 | ||
Beta | 0.89 | ||
Volatility % | 24.86 | ||
14-Day RSI | 53.55 | ||
14-Day ATR (€) | 0.000007 | ||
20-Day SMA (€) | 3.62 | ||
12-1 Month Momentum % | -12.98 | ||
52-Week Range (€) | 2.48 - 7.4 | ||
Shares Outstanding (Mil) | 1.14 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ampio Pharmaceuticals Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ampio Pharmaceuticals Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Ampio Pharmaceuticals Inc Frequently Asked Questions
What is Ampio Pharmaceuticals Inc(FRA:APH0)'s stock price today?
The current price of FRA:APH0 is €3.62. The 52 week high of FRA:APH0 is €7.40 and 52 week low is €2.48.
When is next earnings date of Ampio Pharmaceuticals Inc(FRA:APH0)?
The next earnings date of Ampio Pharmaceuticals Inc(FRA:APH0) is 2024-07-08 Est..
Does Ampio Pharmaceuticals Inc(FRA:APH0) pay dividends? If so, how much?
Ampio Pharmaceuticals Inc(FRA:APH0) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |